XNAS · Healthcare · Medical Devices
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | Q1 2026 | -0.27 | -0.32 | -18.52% | $12.1M | ❌ Miss | +1.24% | -8.12% | — |
| 2026-03-17 | Q4 2025 | -0.21 | -0.23 | -9.52% | $10.4M | ❌ Miss | -3.67% | -15.59% | -5.91% |
| 2025-11-06 |
| Q3 2025 |
| -0.20 |
| -0.21 |
| -5.00% |
| $8.9M |
| ❌ Miss |
| — |
| — |
| — |
| 2025-08-12 | Q2 2025 | -0.20 | -0.21 | -5.00% | $9.2M | ❌ Miss | +4.08% | -0.76% | +5.22% |
| 2025-02-26 | Q4 2024 | -0.16 | -0.20 | -25.00% | $7.8M | ❌ Miss | -17.51% | -17.71% | -30.49% |
| 2024-11-07 | Q3 2024 | -0.17 | -0.18 | -5.88% | $8.1M | ❌ Miss | -13.19% | -16.24% | +9.24% |
| 2024-08-07 | Q2 2024 | -0.20 | -0.16 | +20.00% | $7.9M | ✅ Beat | +40.68% | +52.64% | +84.63% |
| 2024-05-07 | Q1 2024 | -0.19 | -0.16 | +15.79% | $7.6M | ✅ Beat | +1.70% | +2.04% | -2.55% |
Showing last 8 quarters.